4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-018061
Director sold 6,667 shares at $13.90 ($92,671)
- Director acquired 6,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ABERCROMBIE GEORGE B · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-24 | Exercise or conversion : show line 1 in the form | +6,667 | $2.63 | $17,534 | 9,667 | D |
| 2021-05-24 | Sale : show line 2 in the form | −6,667 | $13.90 | $92,671 | 3,000 | D |
| Open-market sales · 6,667 sh · avg $13.90 · $92,671 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-24 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option | −6,667 | 10,000 | D |
Loading xslF345X03/form4.xml…